266 related articles for article (PubMed ID: 33239656)
21. Herbal drug ninjin'yoeito accelerates myelopoiesis but not erythropoiesis in vitro.
Inoue T; Kulkeaw K; Muennu K; Tanaka Y; Nakanishi Y; Sugiyama D
Genes Cells; 2014 May; 19(5):432-40. PubMed ID: 24636045
[TBL] [Abstract][Full Text] [Related]
22. MIP-1alpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.
Oba Y; Lee JW; Ehrlich LA; Chung HY; Jelinek DF; Callander NS; Horuk R; Choi SJ; Roodman GD
Exp Hematol; 2005 Mar; 33(3):272-8. PubMed ID: 15730850
[TBL] [Abstract][Full Text] [Related]
23. Identifying bias in CCR1 antagonists using radiolabelled binding, receptor internalization, β-arrestin translocation and chemotaxis assays.
Gilchrist A; Gauntner TD; Fazzini A; Alley KM; Pyen DS; Ahn J; Ha SJ; Willett A; Sansom SE; Yarfi JL; Bachovchin KA; Mazzoni MR; Merritt JR
Br J Pharmacol; 2014 Nov; 171(22):5127-38. PubMed ID: 24990525
[TBL] [Abstract][Full Text] [Related]
24. Expression of the chemokine receptor CCR1 promotes the dissemination of multiple myeloma plasma cells
Zeissig MN; Hewett DR; Panagopoulos V; Mrozik KM; To LB; Croucher PI; Zannettino ACW; Vandyke K
Haematologica; 2021 Dec; 106(12):3176-3187. PubMed ID: 33147936
[TBL] [Abstract][Full Text] [Related]
25. Runx1 is involved in primitive erythropoiesis in the mouse.
Yokomizo T; Hasegawa K; Ishitobi H; Osato M; Ema M; Ito Y; Yamamoto M; Takahashi S
Blood; 2008 Apr; 111(8):4075-80. PubMed ID: 18250229
[TBL] [Abstract][Full Text] [Related]
26. MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts.
Vallet S; Raje N; Ishitsuka K; Hideshima T; Podar K; Chhetri S; Pozzi S; Breitkreutz I; Kiziltepe T; Yasui H; Ocio EM; Shiraishi N; Jin J; Okawa Y; Ikeda H; Mukherjee S; Vaghela N; Cirstea D; Ladetto M; Boccadoro M; Anderson KC
Blood; 2007 Nov; 110(10):3744-52. PubMed ID: 17715391
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation.
Wierenga AT; Vellenga E; Schuringa JJ
Blood; 2010 Jun; 115(22):4367-76. PubMed ID: 20339093
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery.
Leonard A; Bonifacino A; Dominical VM; Luo M; Haro-Mora JJ; Demirci S; Uchida N; Pierciey FJ; Tisdale JF
Br J Haematol; 2019 Jul; 186(2):286-299. PubMed ID: 30972754
[TBL] [Abstract][Full Text] [Related]
29. GATA-1 transcription factor is up-regulated in bone marrow hematopoietic progenitor CD34(+) and erythroid CD71(+) cells in myelodysplastic syndromes.
Maratheftis CI; Bolaraki PE; Voulgarelis M
Am J Hematol; 2007 Oct; 82(10):887-92. PubMed ID: 17570514
[TBL] [Abstract][Full Text] [Related]
30. Telomere length is positively associated with the expression of IL‑6 and MIP‑1α in bone marrow mesenchymal stem cells of multiple myeloma.
Li S; Jiang Y; Li A; Liu X; Xing X; Guo Y; Xu Y; Hao Y; Zheng C
Mol Med Rep; 2017 Sep; 16(3):2497-2504. PubMed ID: 28677723
[TBL] [Abstract][Full Text] [Related]
31. Extracellular vesicle cross-talk in the bone marrow microenvironment: implications in multiple myeloma.
Wang J; Faict S; Maes K; De Bruyne E; Van Valckenborgh E; Schots R; Vanderkerken K; Menu E
Oncotarget; 2016 Jun; 7(25):38927-38945. PubMed ID: 26950273
[TBL] [Abstract][Full Text] [Related]
32. Spatiotemporal CCR1, CCL3(MIP-1α), CXCR4, CXCL12(SDF-1α) expression patterns in a rat spinal cord injury model of posttraumatic neuropathic pain.
Knerlich-Lukoschus F; von der Ropp-Brenner B; Lucius R; Mehdorn HM; Held-Feindt J
J Neurosurg Spine; 2011 May; 14(5):583-97. PubMed ID: 21332278
[TBL] [Abstract][Full Text] [Related]
33. Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis.
Gutiérrez L; Tsukamoto S; Suzuki M; Yamamoto-Mukai H; Yamamoto M; Philipsen S; Ohneda K
Blood; 2008 Apr; 111(8):4375-85. PubMed ID: 18258797
[TBL] [Abstract][Full Text] [Related]
34. SENP1-mediated GATA1 deSUMOylation is critical for definitive erythropoiesis.
Yu L; Ji W; Zhang H; Renda MJ; He Y; Lin S; Cheng EC; Chen H; Krause DS; Min W
J Exp Med; 2010 Jun; 207(6):1183-95. PubMed ID: 20457756
[TBL] [Abstract][Full Text] [Related]
35. Impact of transcription factors KLF1 and GATA1 on red blood cell antigen expression: a review.
Lopez GH; Sarri ME; Flower RL; Hyland CA
Immunohematology; 2024 Apr; 40(1):1-9. PubMed ID: 38739025
[TBL] [Abstract][Full Text] [Related]
36. Dyserythropoiesis of myelodysplastic syndromes.
Lefèvre C; Bondu S; Le Goff S; Kosmider O; Fontenay M
Curr Opin Hematol; 2017 May; 24(3):191-197. PubMed ID: 28072603
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional States and Chromatin Accessibility Underlying Human Erythropoiesis.
Ludwig LS; Lareau CA; Bao EL; Nandakumar SK; Muus C; Ulirsch JC; Chowdhary K; Buenrostro JD; Mohandas N; An X; Aryee MJ; Regev A; Sankaran VG
Cell Rep; 2019 Jun; 27(11):3228-3240.e7. PubMed ID: 31189107
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic dysregulation of GATA1 is involved in myelodysplastic syndromes dyserythropoiesis.
Hopfer O; Nolte F; Mossner M; Komor M; Kmetsch A; Benslasfer O; Reissmann M; Nowak D; Hoelzer D; Thiel E; Hofmann WK
Eur J Haematol; 2012 Feb; 88(2):144-53. PubMed ID: 21967505
[TBL] [Abstract][Full Text] [Related]
39. The Chemokine CCL3 Regulates Myeloid Differentiation and Hematopoietic Stem Cell Numbers.
Staversky RJ; Byun DK; Georger MA; Zaffuto BJ; Goodman A; Becker MW; Calvi LM; Frisch BJ
Sci Rep; 2018 Oct; 8(1):14691. PubMed ID: 30279500
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow hematopoietic dysfunction in untreated chronic lymphocytic leukemia patients.
Manso BA; Zhang H; Mikkelson MG; Gwin KA; Secreto CR; Ding W; Parikh SA; Kay NE; Medina KL
Leukemia; 2019 Mar; 33(3):638-652. PubMed ID: 30291337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
